Interview: Chloe Deutscher: Director of Business Development: PsyGen

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Latest News

Medicare’s CBD Shift Signals Validation—But a Looming Hemp Ban Clouds the Path for Seniors

HCN News Team2026-01-06T10:11:49-08:00January 6th, 2026|

NEW YORK- For decades, seniors managing chronic pain, inflammation, anxiety, or sleep disruption have relied largely on pharmaceuticals—often with long lists of side effects. That landscape is starting to change. Medicare is preparing to recognize cannabidiol ...

DEA Increases Psychedelics Production Quotas for 2026

HCN News Team2026-01-06T08:52:03-08:00January 6th, 2026|

WASHINGTON – The Drug Enforcement Administration has approved expanded production limits for key psychedelics, setting the stage for increased scientific inquiry into substances like psilocybin and DMT next year. In a final order published Monday ...

Indiana Republicans Propose Statewide Oversight for Craft Hemp Market

HCN News Team2026-01-06T07:50:49-08:00January 6th, 2026|

INDIANAPOLIS – Three Republican members of the Indiana House introduced legislation this week to impose a structured permitting system on the sale and distribution of craft hemp products, a category that includes flower, beverages and ...

Interview: Chloe Deutscher: Director of Business Development: PsyGen

About the Author: HCN News Team

Latest News

Medicare’s CBD Shift Signals Validation—But a Looming Hemp Ban Clouds the Path for Seniors

DEA Increases Psychedelics Production Quotas for 2026

Indiana Republicans Propose Statewide Oversight for Craft Hemp Market

Navigate

Legal

About

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405

Enter your email & receive instant access to Uncovering the Hidden Costs of Employee Non-Compliance

If you are not automatically redirected after submission, please email us at [email protected].

By providing your email address, you agree to our Privacy Policy & Terms of Use and consent to receive emails from Paylient and Highly Capitalized.

We are committed to protecting your privacy with responsible data practices. We will NEVER sell nor share your personal information with third parties outside of the producers of this eBook — Paylient and Highly Capitalized.

Interview: Chloe Deutscher: Director of Business Development: PsyGen

About the Author: HCN News Team

Share This Story, Choose Your Platform!

Related Posts

Latest News

Medicare’s CBD Shift Signals Validation—But a Looming Hemp Ban Clouds the Path for Seniors

DEA Increases Psychedelics Production Quotas for 2026

Indiana Republicans Propose Statewide Oversight for Craft Hemp Market

Navigate

Legal

About

HCN Media Group | 171 Pier Avenue, Suite 177, Santa Monica, California, 90405